Newsfeeds Archive - Spark Newswire

1 minute read

Erasca Initiates SEACRAFT-2 Pivotal Phase 3 Trial Evaluating Naporafenib Plus Trametinib In Patients With NRAS-Mutant Melanoma

June 18, 8:05 AM

Naporafenib is a potential first-in-class and best-in-class pan-RAF inhibitor for multiple RAS/MAPK pathway-driven tumors and has been dosed in over 500 patients to dateFavorable mOS and mPFS demonstrated in pooled

ERAS

2 minute read

e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday

By Avi Kapoor

May 23, 10:26 AM

U.S. stocks were mixed, with the Dow Jones index falling around 250 points on Thursday. Shares of e.l.f.…

ACIU

2 minute read

$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

By Avi Kapoor

May 23, 8:47 AM

The Dow Jones index closed lower by over 200 points on Wednesday. When insiders purchase or sell shares,…

BRN

2 minute read

DXC Technology Issues Weak Outlook, Joins Take-Two Interactive And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

By Avi Kapoor

May 17, 5:34 AM

U.S. stock futures were slightly lower this morning, with the Dow futures falling around 10 points on Friday.…

ASTS

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

April 19, 8:08 AM

Gainers Chromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday’s pre-market session. The company’s market cap…

CHRO

3 minute read

Erasca Announces Two Clinical Trial Collaboration And Supply Agreements For Trametinib To Evaluate Naporafenib Combination In SEACRAFT-1 And SEACRAFT-2 Trials

By Benzinga Newsdesk

February 14, 9:10 AM

Naporafenib is a potential first-in-class and best-in-class pan-RAF inhibitor in multiple RAS/MAPK pathway-driven tumors Initial SEACRAFT-1 Phase 1b combination data in RAS Q61X solid tumors expected between Q2-Q4

ERAS

2 minute read

RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying

By Avi Kapoor

December 11, 9:34 AM

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

COMM

2 minute read

$1.7M Bet On Erasca? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

By Avi Kapoor

December 7, 9:33 AM

The Dow Jones closed lower by around 70 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AWH

3 minute read

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

November 28, 3:44 PM

Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.

ALLG